Department of Internal Medicine, Respiratory Medicine and Ventilatory Support, Medical Mission Hospital, Central Clinic Würzburg, Academic Teaching Hospital of the Julius Maximilian University of Würzburg, Würzburg, Germany.
Department of Pneumology, Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
Respiration. 2022;101(8):784-792. doi: 10.1159/000524369. Epub 2022 Apr 27.
Anxiety and depression are common in pulmonary hypertension (PH) and health-related quality of life (HRQoL) is reduced. Sufficient analyses in incident and prevalent patients are lacking, so we provide a comparative analysis of these groups with focus on anxiety, depression and HRQoL.
Depression, anxiety and HRQoL were retrospectively analyzed by Hospital Anxiety and Depression Scale (HADS) and Short Form 36 questionnaire in 91 prevalent and 21 incident PH outpatients from a German tertiary care center specialized in PH. The acquired data as well as hemodynamic and functional parameters of prevalent and incident cases were compared.
HRQoL was reduced in both cohorts of patients. Incident patients had significantly worse HRQoL in physical dominated scales than prevalent patients (physical component summary score: p = 0.02; physical role performance: p < 0.01). Depression and anxiety were more pronounced in prevalent patients (elevated depression scales: 28.6% of incident group, 35.2% of prevalent group, elevated anxiety scores: 28.6% of incident group, 39.6% of prevalent group). The groups did not differ in hemodynamic data, but incident patients had significantly lower cardiac biomarkers such as NT-proBNP (p = 0.016) and hs-troponin (p = 0.017). The time since diagnosis was a predictor of the subscale physical role performance (p < 0.001).
Physical domains of HRQoL seem to be more limited in incident patients with PH. Anxiety and depression are frequent in both groups. A screening for anxiety and depression is important from the onset of the diagnosis, and patients should receive appropriate therapy to improve HRQoL, anxiety and depression.
焦虑和抑郁在肺动脉高压(PH)中很常见,健康相关生活质量(HRQoL)降低。在新发病例和现患病例中,缺乏充分的分析,因此我们对这两组病例进行了比较分析,重点是焦虑、抑郁和 HRQoL。
回顾性分析了德国一家专门治疗 PH 的三级医疗机构的 91 名现患 PH 和 21 名新发病例的门诊患者的医院焦虑抑郁量表(HADS)和 36 项简短健康状况调查问卷(SF-36)。比较了现患和新发病例的获得数据以及血流动力学和功能参数。
两组患者的 HRQoL 均降低。新发病例的躯体主导量表的 HRQoL 明显差于现患病例(躯体成分综合评分:p = 0.02;躯体角色功能:p < 0.01)。现患病例的抑郁和焦虑更为明显(抑郁量表升高:新发病例组 28.6%,现患组 35.2%;焦虑评分升高:新发病例组 28.6%,现患组 39.6%)。两组患者在血流动力学数据上无差异,但新发病例的心脏生物标志物如 NT-proBNP(p = 0.016)和 hs-肌钙蛋白(p = 0.017)明显降低。诊断后时间是躯体角色功能亚量表的预测因素(p < 0.001)。
PH 新发病例的躯体 HRQoL 似乎更为受限。两组患者均常伴有焦虑和抑郁。从诊断开始,对焦虑和抑郁进行筛查很重要,应给予适当的治疗以改善 HRQoL、焦虑和抑郁。